NeuBase Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
NeuBase Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q3 2023.
  • NeuBase Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2023 was 411 %, a 50.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 411 -417 -50.3% Sep 30, 2023
Q2 2023 504 -496 -49.6% Jun 30, 2023
Q1 2023 711 -526 -42.5% Mar 31, 2023
Q4 2022 739 Dec 31, 2022
Q3 2022 828 Sep 30, 2022
Q2 2022 1K Jun 30, 2022
Q1 2022 1.24K Mar 31, 2022
Q3 2019 405 +89.5 +28.4% Sep 30, 2019
Q2 2019 365 +73.2 +25.1% Jun 30, 2019
Q1 2019 495 +203 +69.8% Mar 31, 2019
Q4 2018 434 +196 +82.1% Dec 31, 2018
Q3 2018 316 +57 +22% Sep 30, 2018
Q2 2018 292 +26.3 +9.9% Jun 30, 2018
Q1 2018 291 +25.2 +9.48% Mar 31, 2018
Q4 2017 238 -154 -39.2% Dec 31, 2017
Q3 2017 259 -175 -40.4% Sep 30, 2017
Q2 2017 265 -271 -50.5% Jun 30, 2017
Q1 2017 266 -405 -60.3% Mar 31, 2017
Q4 2016 392 -358 -47.7% Dec 31, 2016
Q3 2016 434 -162 -27.1% Sep 30, 2016
Q2 2016 536 +66.3 +14.1% Jun 30, 2016
Q1 2016 671 +340 +103% Mar 31, 2016
Q4 2015 750 +531 +243% Dec 31, 2015
Q3 2015 596 +321 +117% Sep 30, 2015
Q2 2015 470 +137 +41.1% Jun 30, 2015
Q1 2015 331 -679 -67.3% Mar 31, 2015
Q4 2014 219 -1.12K -83.7% Dec 31, 2014
Q3 2014 274 -182 -39.9% Sep 30, 2014
Q2 2014 333 +2.79 +0.85% Jun 30, 2014
Q1 2014 1.01K +865 +596% Mar 31, 2014
Q4 2013 1.34K +1.24K +1282% Dec 31, 2013
Q3 2013 456 +394 +627% Sep 30, 2013
Q2 2013 330 +299 +973% Jun 30, 2013
Q1 2013 145 +117 +411% Mar 31, 2013
Q4 2012 96.9 Dec 31, 2012
Q3 2012 62.8 Sep 30, 2012
Q2 2012 30.8 Jun 30, 2012
Q1 2012 28.4 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.